companies incyte-corp 
Harvard Corporate Governance
APRIL 29, 2024
This concept extends traditional insider trading paradigms to situations where an individual, privy to material non-public information (MNPI) regarding one company (Company A), capitalizes on that knowledge to trade securities in another company (Company B). more…)
Benzinga
OCTOBER 3, 2022
Incyte Corp (NASDAQ: INCY ) has agreed to acquire Villaris Therapeutics , an asset-centric biopharmaceutical company seeded by Medicxi and focused on developing novel antibody therapeutics for vitiligo, a condition in which the skin loses its pigment cells.
Reynolds Holding
MARCH 28, 2022
an oncology-focused biopharmaceutical company. In this position, according to the SEC, he “closely tracked the stock prices, drug products and development pipelines of other biopharmaceutical companies.”. Responding to unsolicited interest in acquiring Medivation, the company hired investment bankers to explore options.
Expert insights. Personalized for you.
120 
Let's personalize your content